Finding rewrites understanding into Parkinson’s disease pathway
This news story reports on a study by Team Hurley that solves a mystery about how the protein Optineurin recognizes unhealthy mitochondria “tagged” by PINK1 and Parkin, enabling their delivery to our body's garbage disposal system.
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
STAT highlights how The Parkinson’s Progression Markers Initiative (PPMI) recently discovered how αSyn-SAA could be a novel tool for precision medicine approaches, earlier intervention, and improved clinical trial design for Parkinson's disease.
Red/yellow brain pigment linked to Parkinson’s disease: Study
This story discusses a study by Team Chen that found that people with Parkinson’s disease have higher than normal levels of a nerve cell-damaging red/yellow pigment called pheomelanin in their substantia nigra, the area of the brain that’s mainly affected by the neurodegenerative disease.
New study puts gut microbiome at the center of Parkinson’s disease pathogenesis
Science Daily covers a study by Team Liddle that says that the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease.
Metagenomics of Parkinson disease implicates the gut microbiome in multiple disease mechanisms
This podcast episode features Haydeh Payami from Team Liddle and discusses how the gut microbiome may play a role in Parkinson's disease according to metagenomics.
Exclusive: Google Cofounder Sergey Brin Has Quietly Donated More Than $1 Billion Toward Parkinson’s Disease
Forbes Magazine spotlights the ASAP initiative and the collective effort to accelerate the pace of discovery and inform the path to a cure for Parkinson's disease.
